FI893163A0 - Förfarande för framställning av 19-substituerade progesteronderivat, vilka är användbara som 19-hydroxylas-inhibitorer - Google Patents

Förfarande för framställning av 19-substituerade progesteronderivat, vilka är användbara som 19-hydroxylas-inhibitorer

Info

Publication number
FI893163A0
FI893163A0 FI893163A FI893163A FI893163A0 FI 893163 A0 FI893163 A0 FI 893163A0 FI 893163 A FI893163 A FI 893163A FI 893163 A FI893163 A FI 893163A FI 893163 A0 FI893163 A0 FI 893163A0
Authority
FI
Finland
Prior art keywords
preparation
hydroxylase inhibitors
derivatives useful
progesterone derivatives
substituted progesterone
Prior art date
Application number
FI893163A
Other languages
English (en)
Finnish (fi)
Other versions
FI893163A (sv
FI92706C (sv
FI92706B (sv
Inventor
Gene Warwick Holbert
John O'neal Johnston
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI893163A0 publication Critical patent/FI893163A0/sv
Publication of FI893163A publication Critical patent/FI893163A/sv
Application granted granted Critical
Publication of FI92706B publication Critical patent/FI92706B/sv
Publication of FI92706C publication Critical patent/FI92706C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI893163A 1988-06-28 1989-06-28 Förfarande för framställning av 19-substituerade progesteronderivat, vilka är användbara som 19-hydroxylas-inhibitorer FI92706C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/212,409 US4910191A (en) 1988-06-28 1988-06-28 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors
US21240988 1988-06-28

Publications (4)

Publication Number Publication Date
FI893163A0 true FI893163A0 (sv) 1989-06-28
FI893163A FI893163A (sv) 1989-12-29
FI92706B FI92706B (sv) 1994-09-15
FI92706C FI92706C (sv) 1994-12-27

Family

ID=22790892

Family Applications (1)

Application Number Title Priority Date Filing Date
FI893163A FI92706C (sv) 1988-06-28 1989-06-28 Förfarande för framställning av 19-substituerade progesteronderivat, vilka är användbara som 19-hydroxylas-inhibitorer

Country Status (20)

Country Link
US (1) US4910191A (sv)
EP (1) EP0348910B1 (sv)
JP (1) JP2729320B2 (sv)
KR (1) KR0160280B1 (sv)
CN (1) CN1033032C (sv)
AT (1) ATE122681T1 (sv)
AU (1) AU610473B2 (sv)
CA (1) CA1321578C (sv)
DE (1) DE68922660T2 (sv)
DK (1) DK167534B1 (sv)
ES (1) ES2075014T3 (sv)
FI (1) FI92706C (sv)
HU (1) HU204066B (sv)
IE (1) IE66338B1 (sv)
IL (1) IL90727A (sv)
NO (1) NO174511B (sv)
NZ (1) NZ229696A (sv)
PH (1) PH25714A (sv)
PT (1) PT90988B (sv)
ZA (1) ZA894754B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4433374A1 (de) * 1994-09-20 1996-03-21 Hoechst Ag 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
AU8988901A (en) 2000-09-18 2002-03-26 Applied Research Systems Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) for treating excess of glucocorticoids
DE102006018888A1 (de) * 2006-04-18 2007-10-25 Bayer Schering Pharma Ag Verfahren zur Herstellung von 4-[17beta-Methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11beta-yl]benzaldehyd-(E)-oxims (Asoprisnil)
ES2400964T3 (es) 2007-04-04 2013-04-15 Sigmoid Pharma Limited Composiciones famacéuticas de ciclosporina
CN102470106B (zh) 2009-05-18 2015-09-23 希格默伊德药业有限公司 包含油滴的组合物
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
CN102268058B (zh) * 2011-05-24 2012-10-10 湖南诺凯生物医药有限公司 制备17α-羟基孕酮或其类似物的方法
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
ES2858517T3 (es) 2014-11-07 2021-09-30 Sublimity Therapeutics Ltd Composiciones que comprenden ciclosporina

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1051693A (sv) * 1962-07-09
US3275622A (en) * 1963-12-18 1966-09-27 Syntex Corp 19-alkylidene-delta4-3, 20-keto pregnanes
US3275621A (en) * 1963-12-18 1966-09-27 Syntex Corp 19-amino-delta4-pregnenes and-10alpha-pregnenes and process for their preparation
US3558673A (en) * 1966-10-29 1971-01-26 Ormonoterapia Richter Spa 10beta-amino-19-nor-pregnanes and method for the preparation thereof
US3849402A (en) * 1971-01-06 1974-11-19 Steele Chem Co Ltd 19-oxygenated and 19-nor delta8(14)-steroid compounds
US4041055A (en) * 1975-11-17 1977-08-09 The Upjohn Company Process for the preparation of 17α-hydroxyprogesterones and corticoids from androstenes
FR2462445A1 (fr) * 1979-07-31 1981-02-13 Roussel Uclaf Nouveaux derives 17-/(hydroxymethyl) (formamido) methylene/steroides, leur procede de preparation et leur application a l'introduction de la chaine laterale hydroxyacetyle
US4322416A (en) * 1980-06-27 1982-03-30 Merrell Dow Pharmaceuticals Inc. 10-Alkynyl steroids
US4289762A (en) * 1980-06-27 1981-09-15 Merrell Dow Pharmaceuticals Inc. 10-(1,2-Propadienyl) steroids as irreversible aromatase inhibitors
US4293548A (en) * 1980-09-02 1981-10-06 Merrell Dow Pharmaceuticals Inc. 18-Substituted pregn-4-ene-3,20-diones
FR2498607A1 (fr) * 1981-01-29 1982-07-30 Roussel Uclaf Nouveau procede de preparation de 17a-hydroxy 17b-hydroxyacetyle steroides, produits intermediaires correspondants et produits finals obtenus
US4495102A (en) * 1982-09-03 1985-01-22 G. D. Searle & Co. Aminoalkyl steroids
US4473564A (en) * 1983-07-12 1984-09-25 Akzo N.V. 19-Thio-androstane derivatives
FR2576025B1 (fr) * 1985-01-14 1987-01-23 Roussel Uclaf Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant
GB8531745D0 (en) * 1985-12-24 1986-02-05 Erba Farmitalia 10beta-alkynyl-4-9(11)-estradiene derivatives

Also Published As

Publication number Publication date
EP0348910B1 (en) 1995-05-17
FI893163A (sv) 1989-12-29
HU204066B (en) 1991-11-28
PH25714A (en) 1991-09-18
DK167534B1 (da) 1993-11-15
US4910191A (en) 1990-03-20
PT90988A (pt) 1989-12-29
EP0348910A3 (en) 1990-03-21
NO174511C (sv) 1994-05-18
FI92706C (sv) 1994-12-27
PT90988B (pt) 1994-11-30
ES2075014T3 (es) 1995-10-01
KR910000588A (ko) 1991-01-29
CN1039593A (zh) 1990-02-14
KR0160280B1 (ko) 1998-11-16
IL90727A (en) 1993-05-13
IL90727A0 (en) 1990-01-18
FI92706B (sv) 1994-09-15
CA1321578C (en) 1993-08-24
CN1033032C (zh) 1996-10-16
NO892678L (no) 1989-12-29
NO892678D0 (no) 1989-06-27
JPH0248598A (ja) 1990-02-19
ZA894754B (en) 1990-05-30
HUT51288A (en) 1990-04-28
DK318589A (da) 1989-12-29
EP0348910A2 (en) 1990-01-03
NZ229696A (en) 1992-03-26
AU3712789A (en) 1990-01-04
DE68922660D1 (de) 1995-06-22
IE66338B1 (en) 1995-12-27
DE68922660T2 (de) 1996-01-18
NO174511B (no) 1994-02-07
IE892086L (en) 1989-12-28
DK318589D0 (da) 1989-06-27
AU610473B2 (en) 1991-05-16
JP2729320B2 (ja) 1998-03-18
ATE122681T1 (de) 1995-06-15

Similar Documents

Publication Publication Date Title
FI893163A0 (sv) Förfarande för framställning av 19-substituerade progesteronderivat, vilka är användbara som 19-hydroxylas-inhibitorer
NO177312C (no) Fremgangsmåte for fremstilling av hirudinderivater med forsinket virkning
ES546866A0 (es) Procedimiento de preparar derivados antihipertensivos
PH25771A (en) 19-fluoro-or cyano-21-hydroxyprogesterone derivatives , process of preparing said compound
NO882030D0 (no) Fremgangsmaate til fremstilling av hydrasinderivater til bruk som antihypertensivt middel.
NO165399C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (5r,6s)-6-((r)-1-hydroksyetyl)-penem-derivater.
NO862648D0 (no) Fremgangsmaate for fremstilling av farenakologisk aktive 2-substituerte-3,4-dibydroksyfenyletylamino-derivater.
NO890328D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 4-amino-2,3-disubstituert-6,7-dihydro-5h-1-pyrindinderivater.

Legal Events

Date Code Title Description
FG Patent granted

Owner name: MERRELL DOW PHARMACEUTICALS, INC.

BB Publication of examined application
MM Patent lapsed

Owner name: MERRELL DOW PHARMACEUTICALS INC.